Ochsner Community Clinical Oncology Program

Ochsner 社区临床肿瘤学计划

• 批准号: 7486211
• 负责人: Jyotsna Fuloria
• 金额: $ 47.67万
• 依托单位: OCHSNER CLINIC FOUNDATION
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 2010-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7486211
• 关键词: Address; Arts; Authorization documentation; Cancer Control; Cancer Patient; Childhood; Cities; Clinic; Clinical Trials; Community Clinical Oncology Program; Community Physician; Confidential Information; Continuing Education; Correlative Study; Development; Disclosure; Doctor of Medicine; Enrollment; Ensure; Foundations; Funding; Head; Health; Hematology; Human Resources; Instruction; Knowledge; Louisiana; Medical Oncology; Methods; Mississippi; Monitor; Names; Numbers; Participant; Pathology; Patients; Pediatric Oncology; Persons; Population; Principal Investigator; Protocols documentation; Radiation Oncology; Recruitment Activity; Research Design; Research Personnel; Role; Rural; Training; Work; abstracting; base; cancer care; cancer therapy; interest; medical specialist; oncology; performance site; programs; skills; social

DESCRIPTION (provided by applicant): The Ochsner CCOP's global aim for the next five years is to provide the unique population we serve in South Louisiana and Mississippi the opportunity to participate in state-of-the-art cancer therapy available only through clinical trials. This culturally rich rural and urban racially mixed patient base has benefited greatly from CCOP participation, with >3500 subjects entered on NCI approved clinical trials since 1983. Other specific aims are: 1} to diversify patients/participants enrolled on clinical trials by adding two largely rural affiliates in Covington and Hammond, Louisiana. 2) To embrace pediatric oncology as a major focus to broaden the CCOP patient base. 3) To establish strong relationships with the 25 Ochsner Satellite Clinics to create a large patient base of potential subjects for Cancer Control. 4) To partner medical oncology with other medical specialists to encourage an exchange of information that will generate enthusiasm for referring patients for clinical trials. 5) To monitor closely the underserved patients/participants to ensure that financial and social barriers are addressed to facilitate their enrollment in clinical trials. 6) To present continuing education programs to community physicians encompassing the latest results from clinical trials to encourage rapid dissemination of knowledge that leads to practice changes positively impacting the cancer patient. 7) To hold interdisciplinary monthly protocol meetings to rigorously review protocols for determining investigators interest and commitment. 8) To utilize to the fullest extent the skills of the highly motivated cancer control coordinator recruited in 2004. 9) To make a priority the training and development of the Co-Pi to assure continuity. 10) To make participation in correlative studies an integral responsibility for investigators enrolling patients on study.

描述（由申请人提供）： Ochsner CCOP在接下来的五年中的全球目标是为我们在路易斯安那州和密西西比州提供的独特人群提供机会，有机会参加仅通过临床试验才能获得的最先进的癌症治疗。自1983年以来，这个文化丰富的农村和城市种族混合的患者基础受益于CCOP的参与，从NCI批准的临床试验中输入了> 3500名受试者。其他具体目标是：1}通过在Covington和Hammond和Hamammond，Louisiana和Hamammona和Hamammona和Hamammona和Hamammona，Louisiana中多样化的患者/参与者进行多样化的患者/参与者的多样化。 2）将小儿肿瘤学作为扩大CCOP患者基础的主要重点。 3）与25个OCHSNER卫星诊所建立牢固的关系，以创建一个庞大的潜在受试者的患者基础，以控制癌症。 4）与其他医学专家合作，促进信息交流，以引起人们对患者进行临床试验的热情。 5）密切监视服务不足的患者/参与者，以确保解决财务和社会障碍，以促进他们参加临床试验的入学率。 6）向社区医生介绍继续教育计划，包括临床试验的最新结果，以鼓励快速传播知识，从而导致实践变化对癌症患者产生积极影响。 7）举行跨学科的每月协议会议，以严格审查协议，以确定调查人员的兴趣和承诺。 8）最大程度地利用了2004年招募的高度动机癌症控制协调员的技能。9）优先考虑Co-Pi的培训和开发以确保连续性。 10）使参与相关研究成为注册研究患者的研究人员不可或缺的责任。